Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
108 hedge funds and large institutions have $938M invested in Portola Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 16 closing their positions.
139% more call options, than puts
Call options by funds: $531K | Put options by funds: $222K
50% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 26
2% less funds holding
Funds holding: 110 → 108 (-2)
10% less capital invested
Capital invested by funds: $1.05B → $938M (-$110M)
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.22M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.46M |
| 3 |
Millennium Management
New York
|
+$8.25M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$7.25M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$13.5M |
| 2 |
A
Abingworth
London,
United Kingdom
|
-$8.17M |
| 3 |
O
OppenheimerFunds
New York
|
-$6.47M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.25M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.02M |
PTLA Hedge Fund Activity: Q3 2014 in Review
108 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q3 2014, worth a combined $938M — down 10% from $1.05B a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of PTLA and 14 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 39 added.
The largest buyer was Fidelity Investments, adding an estimated $9.22M. The largest seller was OrbiMed, cutting an estimated $13.5M.
- 108 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q3 2014, down from 110 in Q2 2014.
- Funds reported $938M of Portola Pharmaceuticals, Inc. stock for Q3 2014, down 10% quarter-over-quarter.
- 14 funds opened new Portola Pharmaceuticals, Inc. positions in Q3 2014 and 16 closed out, a net change of -2 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q3 2014 was Fidelity Investments, an estimated $9.22M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q3 2014 was OrbiMed, an estimated $13.5M sold.
Based on aggregated 13F filings for Q3 2014.